NICE NG89 recommendations for extended pharmacological thromboprophylaxis - is it justified and is it cost effective: a rebuttal from the British Society for Haematology - response to Lester et al.

Citation:
Stansby, G., I. Donald, P. Barry, D. Dawoud, and C. Sharpin, "NICE NG89 recommendations for extended pharmacological thromboprophylaxis - is it justified and is it cost effective: a rebuttal from the British Society for Haematology - response to Lester et al.", British journal of haematology, vol. 186, issue 5, pp. 788-789, 2019.